How much funding has Darts Bio (达石药业) raised?

Darts Bio (达石药业) has raised $32.1M in total funding, most recently a Series B round.

Who are Darts Bio (达石药业)'s investors?

Darts Bio (达石药业)'s investors include Kaitai Capital.

When was Darts Bio (达石药业) founded?

Darts Bio (达石药业) was founded in 2017.

Where is Darts Bio (达石药业) headquartered?

Darts Bio (达石药业) is headquartered in Zhongshan, China.

What industry is Darts Bio (达石药业) in?

Darts Bio (达石药业) operates in Biotech.

How many employees does Darts Bio (达石药业) have?

Darts Bio (达石药业) has 201-500 employees.

Darts Bio (达石药业)

Zhongshan, China · Founded 2017 · $32.1M raised

Biotech

Headquarters: Zhongshan
Employees: 201–500
Founded: 2017
Business Model: B2B

Website: dartsbio.com
Total Funding: $32.1M
Last Round: $14.5M Series BJan 2023
Rounds: 3

About

Dartsbio Pharmaceutical Co., Ltd. (达石药业) is a Zhongshan, China-based pharmaceutical company focused on innovative macromolecule drug research and development. The company is dedicated to discovering and developing biologics and novel medicines that improve human quality of life, operating with a team of 201 to 500 employees. Founded in 2017, Dartsbio is a privately held company in the pharmaceutical manufacturing sector, building a pipeline of innovative drug candidates across therapeutic areas neglected by large pharmaceutical companies.

Summary

Darts Bio (达石药业) is a Biotech company based in Zhongshan, China, founded in 2017. It has raised $32.1M in total across 3 rounds, most recently a $14.5M Series B round in Jan 2023. Investors include Kaitai Capital.